News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Multiply Labs and Thermo Fisher Scientific Enhance Collaboration for Automated Cell Expansion and Separation in Cell Therapy Manufacturing
Monday, February 12, 2024Thermo Fisher Scientific has made significant strides in advancing cell therapy development and manufacturing through a collaboration with Multiply Labs robotic technology This partnership aims to enhance efficiency
Corvus Pharmaceuticals Receives Orphan Drug Designation for Soquelitinib in Treating T Cell Lymphoma
Friday, February 09, 2024Corvus Pharmaceuticals Inc has announced today that the US Food and Drug Administration has granted Orphan Drug Designation for soquelitinib a clinicalstage biopharmaceutical companys lead ITK inhibitor candidate
SmartCella Receives GMP Approval for Manufacturing and Quality Control Testing of Cell Therapies
Thursday, February 08, 2024SmartCellas subsidiary ProCella has received approval from the Swedish Medicinal Product Agency for the manufacturing and quality control testing of sterile biological medicinal products for cell therapy
Halia Therapeutics Partners with Canary Speech to Utilize Advanced AI-Driven Speech Technology for Developing Novel Therapeutics Targeting Neuroinflammation
Wednesday, February 07, 2024Halia Therapeutics a company specializing in neuroinflammationtargeting drugs and Canary Speech a leader in artificial intelligence vocal biomarker technology have announced a collaboration
Linnea SA of Switzerland and State University of Campinas (Unicamp) in Brazil Form Strategic Alliance to Advance Cannabinoid Research
Wednesday, February 07, 2024Linnea SA a distinguished global manufacturer of Active Pharmaceutical Ingredients with over four decades of experience and a wellestablished presence in the Latin American region is thrilled to announce the initiation of a strategic partnership
Bayer AG Partners with TetraScience to Boost Innovation through Enhanced Scientific Data Utilization
Tuesday, February 06, 2024Bayer AG a renowned global pharmaceutical and biotechnology company has entered into a partnership with TetraScience a leading provider of Scientific Data and AI Cloud solutions This collaboration aims to optimize the utilization of scientific data
ProfoundBio Commences Phase 1/2 Clinical Trial for PRO1107: Targeting PTK7 with Unique Hydrophilic MMAE-Based Linker-Drug
Monday, February 05, 2024ProfoundBio a biotechnology firm currently in the clinical stage has commenced dosing in the Phase clinical trial of PRO an innovative antibodydrug conjugate therapy for cancer ProfoundBio emphasized the significance of this milestone stating
Graviton Bioscience Secures Strategic Funding from Sanofi to Advance Development of Innovative ROCK2 Inhibitors
Friday, February 02, 2024Graviton Bioscience a clinicalstage biotechnology firm focused on developing therapies that inhibit RhoRhoassociated coiledcoil containing protein kinase ROCK has recently secured a strategic investment from Sanofi
RS Oncology Initiates Phase 2 Trial (MITOPE) for RSO-021 in Malignant Pleural Mesothelioma and Lung Metastases
Friday, February 02, 2024RS Oncology a clinicalstage biotechnology company focused on developing innovative therapies for mesothelioma and other diseases has successfully administered the first dose to a patient in the Phase dose expansion
AustinPx and Microsize Collaborate on KinetiSol® Technology
Thursday, February 01, 2024AustinPx and Microsize two contract development and manufacturing organizations have formed a strategic partnership to expedite the commercial application of AustinPxs KinetiSol Technology platform Through this collaboration AustinPxs clients will be...
